Drug resistance testing is recommended for the management of patients with HIV-1 infection. Celera ViroSeq™ HIV-1 Genotyping System is the most widely used genotypic HIV drug resistance testing. The assay produces 1,302 nucleotide sequences comprising codons 1-99 of the protease gene and 1-335 of the reverse transcriptase gene. Genotyping result is linked to an interpretive algorithm, for example, Virco® TYPE HIV-1 to generate drug resistance profile.
CITATION STYLE
Xu, F., & Dong, J. (2012). HIV-1 genotyping and virtual phenotyping. In Modern Clinical Molecular Techniques (pp. 97–121). Springer New York. https://doi.org/10.1007/978-1-4614-2170-2_8
Mendeley helps you to discover research relevant for your work.